This was the most frustrating call yet. It seems like CYDY is close, but far. For example, in a PR yesterday, NP cites the EIND data before information from the trials. Every PR is a chance to prove or subvert the case. All logical cases are built on solid foundations. The solid foundation here is trial data first, articles published on LL next and then anecdotal data from eINDs in that order...EVERY TIME. I have been a SH since early 2012 and was buddies / partner with prior CEO and introduced a prior board member to the company. I know there is good science, first hand, which is why I am so pissed about the CEO. There are some on this board who have more info / context on NP than I do, but not many.
Market Data 
Markets 
